AmarbIo.com
About AmarbIo.com
Amarillo Biosciences is an emerging specialty biopharmaceutical company working in Phase II human clinical trials with a well-characterized therapeutic agent, low-dose interferon alpha. The interferon alpha in our oral formulation is produced naturally from human cells, not by recombinant technology. We are studying this product in human clinical trials in several conditions where innovative and patient-friendly therapies are needed.
